SBI Securities’s iSpecimen ISPC Stock Holding History

SBI Securities’s Portfolio ISPC Stock Details ISPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Buy	+1	New	+$4	﹤0.01%	4021
2026 Q1	–	Hold	0	–	–	–	3943
2025 Q4	–	Hold	0	–	–	–	3999
2025 Q3	–	Hold	0	–	–	–	4103
2025 Q2	–	Hold	0	–	–	–	4043
2025 Q1	–	Hold	0	–	–	–	4093
2024 Q4	–	Hold	0	–	–	–	3999

Other funds holding ISPC

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

SBI Securities's ISPC Position: Q2 2026 in Review

SBI Securities opened a new position in iSpecimen (ISPC) in Q2 2026: 1 share worth $3. The stake represents ﹤0.01% of the portfolio and ranks #4021 among its holdings.

8 funds tracked by Wall St. Rank hold ISPC as of Q2 2026.

SBI Securities held 1 share of iSpecimen worth $3 as of Q2 2026.
iSpecimen was a new SBI Securities position in Q2 2026.
iSpecimen made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #4021 holding.
8 funds tracked by Wall St. Rank held iSpecimen as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.